Abstract
Cancer survivors are at higher risk of developing HPV-associated cancers later in life, yet their HPV vaccination rates remain lower than the general population. Improving HPV vaccination uptake among survivors is essential to preventing second malignancies. We interviewed HPV vaccine eligible adolescent and young adult (AYA) cancer survivors (18–26 years) and caregivers of HPV vaccine eligible childhood cancer survivors approaching the AYA age range (9–17 years) about their HPV vaccine experiences and preferences as informed by the HPV Vaccination Roundtable Best Practices. Interviews (N = 20) were recorded, transcribed, and analyzed using interpretive description. Of AYA survivors (n = 10), 50% had received at least one HPV vaccine dose. Of caregivers (n = 10), 30% reported their child had received at least one HPV vaccine dose. Three distinct categories emerged including (1) HPV vaccine knowledge, (2) HPV vaccination recommendation preferences, and (3) HPV vaccination reminder preferences. The first two categories were oncology focused. Participants lacked knowledge regarding HPV vaccine safety and applicability due to their complex cancer history. Most participants strongly preferred that their oncologist provide an HPV vaccine recommendation. The third category was mixed, with some participants preferring oncology-based HPV vaccine reminders while others preferred primary care-based reminders. Almost all participants preferred digital reminders (e.g., text messages). Our results suggest that oncologists play an essential role in recommending the HPV vaccine and providing information to assist survivors and caregivers with vaccine decision-making. Additionally, HPV vaccination uptake among pediatric and childhood and AYA survivors could be improved through the use of tailored, electronically delivered vaccine reminders.
Similar content being viewed by others
Data Availability
Not applicable.
References
Bhatia S, Sklar C (2002) Second cancers in survivors of childhood cancer. Nat Rev Cancer 2(2):124–132. https://doi.org/10.1038/nrc722
Huang SF, Li HF, Liao CT, Wang HM, Chen IH, Chang J-C, Chen YJ, Cheng AJ (2012) Association of HPV infections with second primary tumors in early-staged oral cavity cancer. Oral Dis 18(8):809–815. https://doi.org/10.1111/j.1601-0825.2012.01950.x
Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Minniear TD, Jackson BE, Gurney JG (2013) Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One 8(8):e70349. https://doi.org/10.1371/journal.pone.0070349
Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H (2013) Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 40(3):187–193. https://doi.org/10.1097/OLQ.0b013e318286bb53
Joura EA, Pils S (2016) Vaccines against human papillomavirus infections: protection against cancer, genital warts or both? Clin Microbiol Infect 22:S125–S127. https://doi.org/10.1016/j.cmi.2016.12.017
Klosky JL, Hudson MM, Chen Y, Connelly JA, Wasilewski-Masker K, Sun CL, Francisco L, Gustafson L, Russell KM, Sabbatini G, Flynn JS, York JM, Giuliano AR, Robison LL, Wong FL, Bhatia S, Landier W (2017) Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol 35(13):3582–3590. https://doi.org/10.1200/JCO.2017.74.1843
Ramsay JM, Mann K, Kaul S, Zamora ER, Smits-Seemann RR, Kirchhoff AC (2018) Follow-up care provider preferences of adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol 7:204–209. https://doi.org/10.1089/jayao.2017.0083
Castellino SM, Allen KE, Pleasant K, Keyes G, Poehling KA, Tooze JA (2019) Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer. J Cancer Surviv 13:730–738. https://doi.org/10.1007/s11764-019-00791-9
Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C (2017) Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics 139(1):e20161764. https://doi.org/10.1542/peds.2016-1764
American Academy of Family Physicians (2018) Human papillomavirus vaccine (HPV). American Academy of Family Physicians. https://www.aafp.org/patient-care/public-health/immunizations/disease-population/hpv.html.
Centers for Disease Control and Prevention (2017) Speaking about HPV vaccine to your colleagues. Centers for Disease Control and Prevention. https://www.cdc.gov/hpv/hcp/speaking-colleagues.html
York JM, Klosky JL, Chen Y, Connelly JA, Wasilewski-Masker K, Giuliano A, Robison LL, Wong FL, Hudson MM, Bhatia S, Landier W (2018) Patient-level predictors of lack of healthcare provider recommendation for human papillomavirus (HPV) vaccination as reported by childhood cancer survivors and their families. J Clin Oncol 36(15_suppl):10514. https://doi.org/10.1200/JCO.2018.36.15_suppl.10514
Kirchhoff AC, Mann K, Warner EL, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Kepka D (2019) HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Hum Vaccin Immunother 15(7-8):1767–1775. https://doi.org/10.1080/21645515.2019.1619407
Bae J, Ford EW, Wu S, Huerta T (2017) Electronic reminder's role in promoting human papillomavirus vaccine use. Am J Manag Care 23(11):e353–e359
American Academy of Pediatrics (2018) Reminder & Recall Systems. American Academy of Pediatrics. https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/immunizations/Practice-Management/Pages/reminder-recall-systems.aspx. Accessed 11/10/2020
Community preventive services task force increasing appropriate vaccination: standing orders. https://www.thecommunityguide.org/sites/default/files/assets/Vaccination-Standing-Orders.pdf. Accessed 5/23/2018
Creswell JW, Poth CN (2018) Qualitative inquiry & research design: choosing among five approaches, 4th edn. Sage, Thousands Oaks
Thorne S, Kirkham SR, O'Flynn-Magee K (2004) The analytic challenge in interpretive description. Int J Qual Methods 3(1):1–11. https://doi.org/10.1177/160940690400300101
Saldaña J (2013) The coding manual for qualitative researchers, 2nd edn. SAGE Publications Ltd, Los Angeles
McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):276–282
Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103(1):164–169. https://doi.org/10.2105/AJPH.2011.300600
Rosenthala SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichninb MD (2011) Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Elsevier Vaccin 29(5):892–895. https://doi.org/10.1016/j.vaccine.2009.12.063
Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S (2014) Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168(1):76–82. https://doi.org/10.1001/jamapediatrics.2013.2752
Harvey AM, Thompson S, Lac A, Coolidge FL (2019) Fear and derision: a quantitative content analysis of provaccine and antivaccine internet memes. Health Educ Behav 46(6):1012–1023. https://doi.org/10.1177/1090198119866886
Whitney CG, Zhou F, Singleton J, Schuchat A, Centers for Disease C, Prevention (2014) Benefits from immunization during the vaccines for children program era - United States, 1994-2013. MMWR Morb Mortal Wkly Rep 63(16):352–355
Acknowledgements
This study would not have been completed without the contributions from the survivors and caregivers. The authors appreciate recruitment support from the Huntsman-Intermountain Adolescent and Young Adult (HIAYA) Program patient navigators as well as content feedback from the HIAYA Patient and Family Advisory Board.
Code Availability
Not applicable.
Funding
The research reported in this publication was supported by the St. Baldrick’s Foundation, Huntsman Cancer Foundation, and the National Cancer Institute of the National Institutes of Health under award numbers P30CA042014 and R03CA216174 (Kirchhoff and Kepka, PIs). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Austin R. Waters, Karely Mann, and Perla L. Vaca Lopez. The first draft of the manuscript was written by Austin R. Waters, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
All study materials and procedures were approved by the University of Utah IRB (IRB# 00113603).
Consent to Participate
Informed consent was obtained from all participants prior to participation in the interview.
Consent for Publication
Not applicable—deidentified data.
Conflict of Interest
Deanna Kepka receives a portion of her salary from American Cancer Society, which receives funding from Merck, for the purpose of Mission: HPV Cancer Free Quality Improvement Initiative.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Waters, A.R., Mann, K., Vaca Lopez, P.L. et al. HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors. J Canc Educ 37, 1519–1524 (2022). https://doi.org/10.1007/s13187-021-01992-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-021-01992-6